The Kardium Journey
Watch the StarFish Medical On Demand Webinar of “Revolutionizing Heart Health: The Kardium Journey” a presentation at Medical Device Playbook Vancouver 2024.
Kevin Chaplin, CEO of Kardium Inc., shares the remarkable story of Kardium’s rise as a pioneer in atrial fibrillation therapy. Since its inception in 2007, Kardium has pushed the boundaries of cardiac care with its innovative Globe® Mapping and Ablation System.
Kevin details Kardium’s 17-year journey from a bold concept to a leader in cardiac innovation. He recounts the company’s beginnings in Burnaby, British Columbia, where a group of visionary engineers set out to tackle one of the most challenging problems in cardiology: effectively treating atrial fibrillation (AFib) with a single, comprehensive solution. Kevin provides a behind-the-scenes look at how the team’s dedication to continuous iteration and problem-solving led to groundbreaking advancements in AFib therapy.
The Globe® Mapping and Ablation System, Kardium’s flagship product, represents the culmination of years of research, development, and clinical trials. This sophisticated catheter-based system combines mapping, ablation, and navigation capabilities, allowing for faster, safer, and more effective treatment of AFib. Kevin highlighted key milestones, including expanding manufacturing in Burnaby, securing substantial funding, and preparing for European commercialization.
Kevin reflects on the challenges of navigating regulatory hurdles and the pivotal decision to pivot toward pulse field ablation technology—an innovative energy source that is reshaping cardiac care. The session provided valuable insights into the resilience and adaptability required to bring a revolutionary medical device to market.
The recording is now available on-demand. This session is an invaluable resource for medtech professionals, innovators, and entrepreneurs seeking to understand the complexities of medical device development and commercialization.
Revolutionizing Heart Health
The Kardium Journey
Presenter Bios:
Kevin Chaplin
Kevin has been with Kardium since 2008 and has been CEO since 2019. He has been active in many areas at Kardium, including product development, marketing, clinical development, business development and financing. Prior to Kardium, Kevin held product management, marketing and technical positions at Kodak, Sierra Wireless and Accenture. He started his career working as an engineer at the deepest gold mine in the world. Kevin has a B.Sc. in Chemical Engineering from the University of Cape Town.
Medical Device Playbook is one of North America’s largest MedTech events for entrepreneurial companies and medical device professionals. Designed to inform and inspire medtech and biotech entrepreneurs, Playbook brings you stories and insights from some of the industry’s most remarkable entrepreneurs and seasoned experts.
StarFish Medical provides award-winning design, development, commercialization, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Digital Health, Cardiovascular, Neurology, Urology, Gastroenterology, Otology, Ophthalmology, and In-Vitro Diagnostics.
StarFish Medical’s technical expertise includes electronics, mechanical, software/firmware systems engineering, in addition to industrial design and human factors. Regulatory Affairs (RA) and Quality Assurance (QA) consultants at StarFish Medical provide regulatory assistance for FDA, CE Mark and Health Canada submissions. Services include QA support for setting up QMS for start-up companies with implementation at the client’s site, and assisting with ISO 13485 certification audits.
Empowering MedTech Innovation®. www.starfishmedical.com
Contact Patrick Dean, Director of Marketing, for media inquiries.